Skip to Main Content


Published by Indigo River Publishing
Distributed by Simon & Schuster

About The Book

“...a wonderfully crafted mystery-thriller…” — Ronald D. Demmans, Author of Eminent Domain

Dr. Lars Sorenson, an ambitious young oncologist, is crushed when the promised funding for his cancer center is withdrawn. An obsessively secretive company, Elijah-Co, appears as a white knight—but with its own agenda.

Lars can conduct human trials on Elijah-Co’s new cancer-killing drugs, but only if he agrees to perform a shadow study of one of them, EJ 181. Animal data suggests that this drug can reverse the aging process. Lars must prove its effectiveness in humans by conducting a clandestine trial. His research takes on greater urgency when he discovers that his wife’s mysterious illness may be cured by EJ 181. Half-truths and lies dot the landscape as Lars pursues Elijah-Co’s true goal of proving that EJ 181 can endow amortality.

Fiction is reality on steroids, and the novel Elijah-Co delivers that. Science fiction, however, needs to have deep roots in reality—the science must be believable. Dan Luedke’s experience with clinical cancer research provides the expertise for a credible scientific platform as Elijah-Co pursues age reversal and amortality.


DR. LARS SORENSON stood in front of the window, staring at nothing in particular. He was waiting for an audience with the new med school dean. This one kept faculty waiting.

KATHRYN (KATE) SORENSON wasn’t having a good day either. She plopped down on the couch at home, determined to finish the novel she’d been reading. No such luck. She just couldn’t concentrate.

About The Author

Dan W. Luedke is a retired medical oncologist and the author of numerous peer-reviewed articles. Dan’s post-retirement, part-time occupation is hospice medical director. He lives with his wife, Susan Luedke, a not-so-retired medical oncologist. They have two children and four grandchildren, who have chosen to live on opposite sides of the country. When they are not begging them to move back to St. Louis, Dan and Susan visit the kids and grandkids as often as possible. Elijah-Co is his first novel.

Product Details

  • Publisher: Indigo River Publishing (April 12, 2022)
  • Length: 272 pages
  • ISBN13: 9781954676107

Browse Related Books

Raves and Reviews

Fans of Robin Cook or Michael Palmer will welcome the arrival of the medical thriller Elijah-Co. A mysterious company represented by Doctor Lars Sorensen’s college sweetheart offers money for his cancer center just after funding suddenly vanished. They put him in charge of human trials on a drug that could be the miracle cure for his wife’s strange illness. Is fate answering Doctor Sorensen’s most ardent wishes, or is something sinister at play? Elijah-Co thrusts Dr. Sorensen into a world he is not ready for, a world of murky morality, flagrant greed, conflicting loyalties and lurking dangers. It is a world that may open the doors to amortality, or from which Doctor Sorensen may not escape alive. You will not want to miss it." — JB Roth, Author of Blunt Force

“The doctor is in! Is it science…or science fiction? Real or imagined? Dan Luedke’s Elijah-Co chronicles one man’s struggle to choose between his professional integrity and his own private war to save his wife. The winner? The reader! Elijah-Co is a wonderfully crafted mystery-thriller with a fast-paced story line filled with nooks and crannies and twists and turns, told by perfectly imperfect characters. Simply put, Elijah-Co is great read. My only question: Does Dan Luedke have another mystery hidden under his lab coat, waiting to be revealed? I hope so…”

– Ronald D. Demmans, Author of Eminent Domain

Resources and Downloads

High Resolution Images